Another consideration will be how many shares are available at time of SFDA approval. If there are a few as it sits now, the price could rise up to $ ,25 or maybe $ .35 on approval news.
However if the new investors get their 100,000,000 plus $ .052 shares registered for sale before the SFDA approval, then I think the flood of shares might stiffle any real run, especially if the new investors could triple their 5 million dollar investment at about $ .15 and not have to worry about whether the tests would sell at all.
Good Luck Axiom, and here's hoping the SFDA approval comes out before the new investors stock becomes eligible for sale.